Robert Morris

Alternate dosing schedules for topotecan in the treatment of recurrent ovarian cancer.

Weekly topotecan in the management of ovarian cancer.

Survival of women diagnosed with malignant, mixed mullerian tumors of the ovary (OMMMT).

Radiation therapy with or without chemotherapy for cervical cancer with periaortic lymph node metastasis.

Diagnostic markers of ovarian cancer by high-throughput antigen cloning and detection on arrays.

Increased expression of hypoxia-inducible factor 1alpha in type I and type II endometrial carcinomas.

Bladder erosion by an intraperitoneal chemotherapy catheter resulting in catheter protrusion through the external urethral meatus.

Topotecan weekly bolus chemotherapy for relapsed platinum-sensitive ovarian and peritoneal cancers.

Second neoplasms in survivors of endometrial cancer: impact of radiation therapy.

Ritonavir blocks AKT signaling, activates apoptosis and inhibits migration and invasion in ovarian cancer cells.

Reduction of hypoxia-induced angiogenesis in ovarian cancer cells by inhibition of HIF-1 alpha gene expression.

Analysis of the expression of human tumor antigens in ovarian cancer tissues.

Sulforaphane induces cell cycle arrest by protecting RB-E2F-1 complex in epithelial ovarian cancer cells.

Feasibility of extension of platinum-free interval with weekly bolus topotecan and subsequent platinum retreatment outcomes in recurrent ovarian cancer.

Ovarian cancer: relevant therapy, not timing, is paramount.

Tumor autoantibodies as biomarkers for predicting ovarian cancer recurrence.

Variants in the Signaling Protein TSAd are Associated with Susceptibility to Ovarian Cancer in BRCA1/2 Negative High Risk Families.

Vulvar/vaginal melanoma: an updated surveillance epidemiology and end results database review, comparison with cutaneous melanoma and significance of racial disparities.

Is the two-tier ovarian serous carcinoma grading system potentially useful in stratifying uterine serous carcinoma? A large multi-institutional analysis.

Patterns of care, predictors, and outcomes of chemotherapy in elderly women with early-stage uterine carcinosarcoma: a population-based analysis.

Phase II study of treatment of advanced ovarian cancer with folate-receptor-targeted therapeutic (vintafolide) and companion SPECT-based imaging agent (99mTc-etarfolatide).

Dietary energy balance modulates ovarian cancer progression and metastasis.

Preface.

Metformin prevents aggressive ovarian cancer growth driven by high-energy diet: similarity with calorie restriction.

Disease extent at secondary cytoreductive surgery is predictive of progression-free and overall survival in advanced stage ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study.

Specific point mutations in key redox enzymes are associated with chemoresistance in epithelial ovarian cancer.

Dual Targeting of Epithelial Ovarian Cancer Via Folate Receptor α and the Proton-Coupled Folate Transporter with 6-Substituted Pyrrolo[2,3-]pyrimidine Antifolates.

The Impact of Androgen Receptor Expression on Endometrial Carcinoma Recurrence and Survival.

Involvement and comfort of gynecologic oncologists in the treatment of pediatric, adolescent, and young adult patients with gynecologic malignancies.

Cyclophosphamide and acrolein induced oxidative stress leading to deterioration of metaphase II mouse oocyte quality.

Mesna (2-mercaptoethane sodium sulfonate) functions as a regulator of myeloperoxidase.

Granulosa Cell Tumors: Novel Predictors of Recurrence in Early-stage Patients.

Dimercapto-1-propanesulfonic acid (DMPS) induces metaphase II mouse oocyte deterioration.

Melatonin prevents hypochlorous acid-mediated cyanocobalamin destruction and cyanogen chloride generation.

Novel expression of CD11b in epithelial ovarian cancer: Potential therapeutic target.

Quality of life, symptoms and care needs in patients with persistent or recurrent platinum-resistant ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study.

Acrolein, a commonly found environmental toxin, causes oocyte mitochondrial dysfunction and negatively affects embryo development.

Serum folate receptor α (sFR) in ovarian cancer diagnosis and surveillance.

Molecular Basis Supporting the Association of Talcum Powder Use With Increased Risk of Ovarian Cancer.

The addition of paclitaxel to doxorubicin and cisplatin and volume-directed radiation does not improve overall survival (OS) or long-term recurrence-free survival (RFS) in advanced endometrial cancer (EC): A randomized phase III NRG/Gynecologic Oncology Group (GOG) study.

Molecular classification of endometrial carcinoma applied to endometrial biopsy specimens: Towards early personalized patient management.

The inhibition of lactoperoxidase catalytic activity through mesna (2-mercaptoethane sodium sulfonate).

Hypochlorous acid reversibly inhibits caspase-3: a potential regulator of apoptosis.

Heat Shock Protein 60 (HSP60) Serves as a Potential Target for the Sensitization of Chemoresistant Ovarian Cancer Cells.

Molecular Basis Supporting the Association of Talcum Powder Use with Increased Risk of Ovarian Cancer.

Comparing mutation frequencies for homologous recombination genes in uterine serous and high-grade serous ovarian carcinomas: A case for homologous recombination deficiency testing in uterine serous carcinoma.

Ovarian cancer modulates the immunosuppressive function of CD11bGr1 myeloid cells via glutamine metabolism.

Impact of positive cytology in uterine serous carcinoma: A reassessment.

Patient-reported outcome changes at the end of life in recurrent platinum-resistant ovarian cancer: An NRG oncology/GOG study.

Talcum powder induces malignant transformation in normal human primary ovarian epithelial cells.

Molecular profiles of endometrial cancer tumors among Black patients.

Computer-Animated Relational Agents in Human Papillomavirus Vaccination Education.

Phase III Randomized Trial of Maintenance Taxanes Versus Surveillance in Women With Advanced Ovarian/Tubal/Peritoneal Cancer: A Gynecologic Oncology Group 0212:NRG Oncology Study.

Targeted therapy of pyrrolo[2,3-d]pyrimidine antifolates in a syngeneic mouse model of high grade serous ovarian cancer and the impact on the tumor microenvironment.

Binding of Intracellular Myeloperoxidase to αV/β1 Integrin Serves as a Mechanism of Survival in Epithelial Ovarian Cancer.

Decreased incidence of febrile neutropenia in Michigan following masking and social distancing orders for the COVID-19 pandemic: A population based cohort study.

The Genomic Landscape of Vulvar Squamous Cell Carcinoma.

Immunological modifications following chemotherapy are associated with delayed recurrence of ovarian cancer.

A Novel Role of Connective Tissue Growth Factor in the Regulation of the Epithelial Phenotype.

Monomeric myeloperoxidase is a specific biomarker for early-stage ovarian cancer.